Delivery Order SPE2DB22D1106-SPE2DB24FEFD7
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $3,804.24 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 0.75 mg/0.5 ml pens. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through November 2026. The IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $5,805.60 contract is for the supply of Trulicity 0.75 mg/0.5 ml pens, a brand name medication. The contract is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and runs through...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract, valued at $1,500.43, to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Trulicity 0.75 mg/0.5 ml pen 0.5 ml medication. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Trulicity 0.75 mg/0.5 ml pens. The contract has a ceiling value of $1,741.68 and a performance period through April 11, 2024. This award is a task order under a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued at up to $999,999,999.00, for delivering pharmaceuticals and medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,322.36 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Trulicity 0.75 mg/0.5 ml pen medication. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $4,169.21 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Trulicity 0.75 mg/0.5 ml pens. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to DLA facilities...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $1,976.64 contract is for the supply of Trulicity 3 mg/0.5 ml pens, a medication used to treat type 2 diabetes. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA,...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract valued at $2,145.44 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Trulicity 0.75 mg/0.5 ml pens. This delivery order falls under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds as the prime contractor, providing a comprehensive range of pharmaceuticals and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $5,870.00 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Trulicity 0.75 mg/0.5 ml pens. This delivery order falls under a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA to provide a comprehensive range of pharmaceutical products and medical supplies in support of military...
- The U.S. Defense Logistics Agency (DLA) awarded a $16,228.07 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Trulicity 0.75 mg/0.5 ml pens, a prescription medication used to treat type 2 diabetes. The contract has an ultimate completion date of August 29, 2024. AmerisourceBergen, the prime contractor, is not operating under a set-aside designation for this award. This contract is likely part of a...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEFD7Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $3,388.85 to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the provision of Trulicity 0.75 mg/0.5 ml pens, a medication used to treat type 2 diabetes. This delivery order falls under a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for AmerisourceBergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 3/15/24 |